NCT04931823 2026-04-03Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid TumorsConjupro Biotherapeutics, Inc.Phase 1 Terminated34 enrolled
NCT06110195 2026-03-31Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck CancerUniversity of ChicagoPhase 1 Terminated42 enrolled